Skip to search formSkip to main contentSkip to account menu

Interleukin-17A Antagonist [EPC]

Known as: Interleukin 17A Antagonist, Interleukin 17A (IL17A) Antagonist, Interleukin-17A Antagonist 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Broadalumab (Siliq)--another IL-17A antagonist for psoriasis.
2017
2017
Membrangebundenes IL-17A und IL-17F zur Herstellung spezifischer monoklonaler Antikörper für die intrazytoplasmatische Zytokinfärbung
Die Charakterisierung der Zytokine beim Haushuhn ist Schwerpunkt vieler Forschungsarbeiten. Insbesondere die IL-17 Zytokine… 
2017
2017
Association between interleukin-17 gene polymorphisms and the risk of laryngeal cancer in a Chinese population.
IL-17 is associated with the occurrence and development of laryngeal cancer. However, no study has reported the association… 
2016
2016
IL-17A 及IL-17RA 在不同恶性程度胶质瘤中表达的研究
2016
2016
Interleukin-17 A-Induced Epithelial-Mesenchymal Transition of Human Intrahepatic Biliary Epithelial Cells : Implications for Primary Biliary Cirrhosis
269 Received August 1, 2016; revised and accepted November 9, 2016. Published online December 3, 2016; doi: 10.1620/tjem.240.269… 
2015
2015
AS und PSA: IL17A-Inhibitor Secukinumab wirkt anhaltend über ein Jahr
— Die ankylosierende Spondylitis (AS) und die Psoriasis-Arthritis (PsA) sind entzündliche Langzeiterkrankungen der Gelenke und… 
Review
2015
Review
2015
The IL-17A G-197A and IL-17F 7488T/C polymorphisms are associated with increased risk of cancer in Asians: a meta-analysis
Background Interleukin-17 (IL-17) is a family of emerged pro-inflammatory cytokines. The IL-17A and IL-17F are two important… 
2014
2014
P066 IL-17A has dual actions in the induction of colitis
2013
2013
Локусная гетерогенность генов il-17a (G197) и IL-17F (161Arg) при злокачественных новообразованиях женских репродуктивных органов
The distribution of polymorphisms of genes of the two main proinflammatory cytokines IL-17A (G197/197A) and IL-17F (His161/161Arg… 
2008
2008
Antagonistes à il-17a, il-17f et il-23p19, et procédés d'utilisation de ceux-ci
La presente invention concerne le blocage, l'inhibition, la reduction, l'antagonisation ou la neutralisation de l'activite d'IL… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)